Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0010941198
Pharmaceuticals
Sales 2024 * | 592M 157M 12.42B | Sales 2025 * | 665M 177M 13.96B | Capitalization | 1.08B 288M 22.76B |
---|---|---|---|---|---|
Net income 2024 * | 53M 14.08M 1.11B | Net income 2025 * | 63M 16.73M 1.32B | EV / Sales 2024 * | 1.83 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.63 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.25% |
Latest transcript on Kamada Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 08/12/13 |
David Tsur
FOU | Founder | 73 | 12/12/90 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 30/12/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 23/12/19 |
Leon Recanati
BRD | Director/Board Member | 76 | 30/04/05 |
David Tsur
FOU | Founder | 73 | 12/12/90 |
1st Jan change | Capi. | |
---|---|---|
+2.99% | 95.18B | |
-4.34% | 37.55B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B | |
+6.22% | 9.09B |